The Food and Drug Administration (FDA) has clarified that the temporary suspension on the injection of AstraZeneca coronavirus disease (COVID-19) vaccines to ages 59 and under will not slow down the government’s vaccine drive.
According to FDA Director General Eric Domingo, the next supply of the said vaccines will arrive by the end of April.
In addition, the remaining dose of AstraZeneca can be consumed by senior citizens, who will not be affected by the alleged side effects of the vaccine.
“Kaya nga ito ‘yung magandang panahon na aralin ‘yung reports na ito, kasi wala na tayong AstraZeneca vaccines, talagang paubos na. At ‘yung atin namang pagsusuri kung ano ang magiging paghahanda natin for the next batch ay gagawin natin within next week. Senior citizens hindi kasama sa group na nakikitang affected sa blood clotting. Pinakamaganda talaga ‘yung benefit-to-risk ratio. Puwedeng ubusin natin ‘yung natitirang doses sa kanila,” said Domingo.
On Thursday, the FDA said it would suspend the use of AstraZeneca vaccines for ages 59 and younger, after a study showed the vaccine may be linked to some incidents of blood clot or blood clotting in the brain and low platelets in vaccinated people. its.
PH vaccine drive unaffected by AstraZeneca suspension: FDA
As many as 86 such cases, or about 0.0003 percent of the 25 million AstraZeneca vaccinated in Europe. In that number, 8 died.
Symptoms of blood clotting are usually seen within 2 weeks after vaccination. Most people affected by blood clotting are women younger than 60 years old. But it was also said that the benefit or protection from AstraZeneca still outweighs the risk or risk resulting from possible side effects.
The FDA will issue new rules regarding the use of the AstraZeneca vaccine next week, ahead of the expected arrival of additional doses of it from the World Health Organization’s COVAX Facility in late April.
“‘Yung mga kasong nakitaan nitong very rare na adverse event, nakita siya during the first vaccine, and there were no cases seen on second vaccines. Kung nabakunahan na sila, tapos OK at walang naging adverse event, of course they will get the second vaccine, dahil walang nakikitang problema sa second dose,” said FDA Director General Eric Domingo.